Another study using TCGA database analysis showed that AHNAK transcript levels were significantly reduced in glioma stem cells with greater proliferation and migration capacity compared to differentiated glioma cells, although there was no significant difference of AHNAK expression in glioblastoma (GBM) and normal brain tissue (64). The gene discussed is AHNAK; the disease is central nervous system cancer.